Antoni Wiedlocha funded by the EEA Poland-Norway grants
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Arnesen EK, Laake I, Veierød MB, Retterstøl K(2024) Saturated fatty acids and total and CVD mortality in Norway: a prospective cohort study with up to 45 years of follow-up Br J Nutr, 1-13(in press) DOI 10.1017/S0007114524001351, PubMed 39279644
Smiseth OA, Rider O, Cvijic M, Valkovič L, Remme EW, Voigt JU(2024) Myocardial Strain Imaging: Theory, Current Practice, and the Future JACC Cardiovasc Imaging(in press) DOI 10.1016/j.jcmg.2024.07.011, PubMed 39269417
Stedal K, Funderud I, Lindstedt K(2024) How Do Patients and Their Supports Experience Temperament Based Therapy With Support (TBT-S)? A Qualitative Study Int J Eat Disord(in press) DOI 10.1002/eat.24289, PubMed 39268920